Rotavirus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Safety and Preliminary Immunogenicity Study of Inactivated Vaccine for Prevention of Rotavirus Infection
Condition:   Rotavirus Infection Interventions:   Biological: Low dosage IRV on a 0- and 28-day schedule;   Biological: Medium dosage IRV on a 0- and 28-day schedule;   Biological: High dosage IRV on a 0- and 28-day schedule;   Biological: Low dosage IRV on a 0- , 28- and 56-day schedule;   Biological: Medium dosage IRV on a 0- , 28- and 56 -day schedule;   Biological: High dosage IRV on a 0- , 28- and 56-day schedule;   Biological: Placebo on day 0, 28;   Biological: Placebo on day 0, 28, 56 Sponsors:   Chinese Academy of Medical Sciences;   Henan Provincal Center for Disease Control and Prevent...
Source: ClinicalTrials.gov - November 13, 2020 Category: Research Source Type: clinical trials